MedPath

Airway Pressure During Nasal High Flow and CPAP in Neonates

Not Applicable
Completed
Conditions
Respiratory Insufficiency
Registration Number
NCT02632799
Lead Sponsor
Research Center of Maternal and Child Health Protection, Armenia
Brief Summary

Nasal High Flow (NHF) and CPAP are established forms of respiratory support in neonates and often produce similar clinical outcomes. The aim of the study was to investigate airway pressure during NHF and CPAP in neonates.

Detailed Description

Methods: A physiological study which measured pressure intra-nasally with micro (750 µm) pressure probes (Millar, USA) in 10 (5M / 5F) healthy newborns with mean gestation age 37.18 (SD 1.29) wk and mean birth weight of 2414 (SD 503.13) g. NHF was applied at 8 L/min (AIRVO 2) through smaller (OPT 314) and larger (OPT 316) Optiflow nasal cannula; CPAP 5 cmH20 was produced by a Bubble CPAP system and nasal mask interface at constant flow 8 L/min (Fisher \& Paykel Healthcare, NZ). Values are expressed in cmH20 as means and standard deviations (SD).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
10
Inclusion Criteria
  • Healthy term newborns
Exclusion Criteria
  • Newborns with any medical problems after birth
  • Absent of parents consents

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Upper airway pressure generated by NHF compared to CPAPUp to 1 hour

Pressure in upper airways

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Neonatal Intensive Care Unit, Research Centre of Maternal and Child Health

🇦🇲

Yerevan, Armenia

RCMCHP

🇦🇲

Yerevan, Armenia

Neonatal Intensive Care Unit, Research Centre of Maternal and Child Health
🇦🇲Yerevan, Armenia

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.